Millennial Outliers
0 Pogledi · 02/08/24
Product Hunt Weekly Digest
0 Pogledi · 02/08/24
45 Minutes to Ledyard
6 Pogledi · 02/08/24
Designing Nature's Half: The Landscape Conservation Podcast
1 Pogledi · 02/07/24
Sweeping The Country with Jimmy Carter & Derik Walker
0 Pogledi · 02/07/24
Vitality Radio Podcast with Jared St. Clair
1 Pogledi · 02/07/24
Leaders and Legends in Government
1 Pogledi · 02/07/24
80k After Hours
2 Pogledi · 02/07/24
Show Me The Money Club
0 Pogledi · 02/07/24
Faces in FinOps
4 Pogledi · 02/07/24
Knicks Fan TV: The Podcast
0 Pogledi · 02/07/24
Founded & Funded
0 Pogledi · 02/07/24
Kremyanskaya Highlights the Benefits of BET Inhibitors in Myelofibrosis
0
0
0 Pogledi·
07/03/23
Dr Kremyanskaya discusses the results from cohort 1 of the MANIFEST trial in treatment-naïve myelofibrosis, differentiating features of pelabresib and recently approved JAK inhibitors, and next steps for the investigation of BET inhibitors in this population.
Prikaži više
0 Komentari
sort Poredaj po
Millennial Outliers
0 Pogledi · 02/08/24
Product Hunt Weekly Digest
0 Pogledi · 02/08/24
45 Minutes to Ledyard
6 Pogledi · 02/08/24
Designing Nature's Half: The Landscape Conservation Podcast
1 Pogledi · 02/07/24
Sweeping The Country with Jimmy Carter & Derik Walker
0 Pogledi · 02/07/24
Vitality Radio Podcast with Jared St. Clair
1 Pogledi · 02/07/24
Leaders and Legends in Government
1 Pogledi · 02/07/24
80k After Hours
2 Pogledi · 02/07/24
Show Me The Money Club
0 Pogledi · 02/07/24
Faces in FinOps
4 Pogledi · 02/07/24
Knicks Fan TV: The Podcast
0 Pogledi · 02/07/24
Founded & Funded
0 Pogledi · 02/07/24
